Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-4,425
Closed -$93K 443
2017
Q2
$93K Sell
4,425
-35,947
-89% -$617K 0.02% 357
2017
Q1
$608K Buy
40,372
+11,600
+40% +$163K 0.14% 242
2016
Q4
$401K Hold
28,772
0.1% 286
2016
Q3
$333K Buy
28,772
+28,707
+44,165% +$359K 0.08% 299
2016
Q2
$1K Hold
65
﹤0.01% 437
2016
Q1
$1K Hold
65
﹤0.01% 430
2015
Q4
$1K Hold
65
﹤0.01% 428
2015
Q3
$1K Hold
65
﹤0.01% 479
2015
Q2
$1K Hold
65
﹤0.01% 485
2015
Q1
$1K Sell
65
-48
-42% -$542 ﹤0.01% 508
2014
Q4
$1K Sell
113
-18
-14% -$190 ﹤0.01% 501
2014
Q3
$1K Sell
131
-51
-28% -$478 ﹤0.01% 525
2014
Q2
$1K Sell
182
-38
-17% -$368 ﹤0.01% 570
2014
Q1
$2K Hold
220
﹤0.01% 474
2013
Q4
$1K Buy
+220
New +$1.31K ﹤0.01% 579

Globeflex Capital's NCIT Position: Q3 2017 in Review

Globeflex Capital sold out of NCI, Inc. (NCIT) in Q3 2017, closing a stake of 4,425 shares — an estimated $93K sold.

Globeflex Capital first reported a position in NCIT in Q4 2013 and held it in 15 quarters. The position peaked at $608K in Q1 2017. 0 funds tracked by Wall St. Rank hold NCIT as of Q3 2017.

  • Globeflex Capital reported no remaining NCI, Inc. position as of Q3 2017 after selling out during the quarter.
  • Globeflex Capital sold 4,425 NCI, Inc. shares in Q3 2017, an estimated $93K.
  • Globeflex Capital first reported a position in NCI, Inc. in Q4 2013 and held it in 15 quarters.
  • Globeflex Capital's NCI, Inc. position peaked at $608K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held NCI, Inc. as of Q3 2017.

Based on Globeflex Capital's 13F filing for Q3 2017, filed 13 Nov 2017.